Jubilant Agri and Consumer Products
- Market cap
- ₹ 2,807 Cr.
- P/E
- 22.3x
- P/B
- 5.93x
- 52-week range
- 1,460 – 2,753.1
- ROE
- 33%
- ROCE
- 40%
- Dividend yield
- 0%
- Debt / equity
- 0.11
- Sector
- Chemicals & Petrochemicals
- Industry
- Specialty Chemicals
- Listed on
- NSE, BSE
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Specialty Chemicals: 130 companies →Jubilant Agri and Consumer Products against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)22.3 against a typical 25.8: cheaper than most peers (1st = cheapest).51st of 129
- Sales growth+18.3% against a typical +25.9% from a year earlier.76th of 112
- Profit growth+4.5% against a typical +42.4% from a year earlier.77th of 102
- Share price, 3 months+5.9% against a typical −5.8%.35th of 118
- Size₹ 2,807 Cr. market value against a typical ₹ 359.6 Cr. (1st = largest).31st of 126
Latest announcements
Exchange filings and their impact on the company.
- NCLT moves demerger to notice stage with Dec 3 hearing; no financial impact yet.
Jubilant Agri and Consumer Products said the NCLT Allahabad Bench has taken up its second motion petition for the demerger with Jubilant Agri Solutions Limited. By order dated October 8, published October 9, the tribunal directed notices to statutory authorities under Section 230(5) and fixed December 3, 2026 as the next hearing date. This is a procedural step that keeps the demerger process on track, with no change to operations or financials until final NCLT approval.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
No up-to-date rating
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | Withdrawn | Stable | 22 Sep 2026 |
Every agency has withdrawn its rating.
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 22 Sep 2026 | Withdrawn | was CARE A+ / CARE A1+ | — | CARE | — | |
| 17 Oct 2025 | New rating | CARE A+ / CARE A1+ | — | CARE | ₹ 570.66 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 11 Aug 2026 | Financial Results | To consider and approve the Un-audited Standalone and Consolidated financial results for the period ended Jun 30, 2026 |
| 26 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 9 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 4 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 8 Aug 2025 | Financial Results | To consider and approve the financial results for the quarter ended Jun 30, 2025 |
| 29 May 2025 | Financial Results | To consider and approve the financial results for the Quarter and Financial Year ended March 31, 2025. |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Dec 2023 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 293 | 358 | 407 | 398 | 398 | 442 | 513 | 451 | 485 | 523 |
| Expenses | 266 | 316 | 365 | 363 | 371 | 379 | 449 | 414 | 453 | 455 |
| Operating Profit | 27 | 42 | 42 | 34 | 27 | 63 | 64 | 37 | 33 | 68 |
| OPM % | 9% | 12% | 10% | 9% | 7% | 14% | 12% | 8% | 7% | 13% |
| Other Income | −46 | 1 | 0 | 0 | 1 | 1 | 0 | −2 | 0 | 1 |
| Interest | 4 | 4 | 4 | 3 | 2 | 2 | 1 | 2 | 2 | 2 |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 |
| Profit before tax | −28 | 35 | 34 | 28 | 21 | 58 | 58 | 29 | 27 | 62 |
| Tax % | −26% | 26% | 26% | 23% | 25% | 24% | 28% | 26% | 25% | 25% |
| Net Profit | −21 | 26 | 25 | 21 | 16 | 44 | 42 | 22 | 20 | 46 |
| EPS in Rs | — | — | — | 14.16 | 10.63 | 29.29 | 28.06 | 14.21 | 13.15 | 30.43 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- 20%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- 24%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 30%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Prices are delayed and for information only. Nothing on this page is investment advice.